Kotoulas SC, Katsaounou P, Riha R, Grigoriou I, Papakosta D, Spyratos D, Porpodis K, Domvri K, Pataka A
Height: 55.3 in
Australia argued that its objective was to reduc[e] smoking rates in Australia by reducing the appeal of tobacco products, increasing the effectiveness of graphic health warnings, and reducing the ability of packages to mislead consumers about the harms of smoking.[6] The complainants attempted to define Australias objective narrowly as reducing smoking prevalence.[7] The panel found the objective to be related to the protection of human health, in particular to improve public health by reducing the use of, and exposure to, tobacco products.[8] The panel also found that Australias objective was legitimate.[9] Viewing Australias public health objective broadly was a pivotal decision that effected the panels other findings
Figures Abstract Background In 2009, the promulgation of US Food and Drug Administration (FDA) tobacco regulation focused attention on cigarette flavor additives
More research is necessary to draw conclusions